15-year outcomes of the JOCRI study (JOCRIED study): a randomised comparison of off-pump and on-pump multiple arterial coronary revascularisation.


Journal

General thoracic and cardiovascular surgery
ISSN: 1863-6713
Titre abrégé: Gen Thorac Cardiovasc Surg
Pays: Japan
ID NLM: 101303952

Informations de publication

Date de publication:
Mar 2023
Historique:
received: 02 04 2022
accepted: 18 07 2022
pubmed: 12 8 2022
medline: 25 2 2023
entrez: 11 8 2022
Statut: ppublish

Résumé

The Japanese Off-Pump Coronary Revascularization Investigation (JOCRI) study reported a non-significant difference in early outcomes and graft patency between off-pump coronary artery bypass grafting and on-pump coronary artery bypass grafting in 2005. The JOCRIED study aimed to review the long-term outcomes of the JOCRI study participants. The JOCRIED study enrolled 123 of the JOCRI study participants completing the clinical follow-up between August 2018 and August 2020; 61 patients in the off-pump group and 62 patients in the on-pump group. The follow-up period was 13.8 ± 2.8 years. The groups were compared regarding mortality, the incidence of major adverse cardiac and cerebrovascular events and repeat revascularisation. The 15-year cumulative survival rate (off-pump vs on-pump, respectively; 77.7% vs 75.3%; p = 0.85), major adverse events-free survival rate (62.5% vs 55.6%; p = 0.27) and repeat revascularisation-free rate (84.8% vs 78.0%; p = 0.16) were not significantly different between the two groups. Revascularisation was the most common major adverse events in the JOCRIED participants. Although percutaneous coronary intervention was performed in 8 patients (13%) in the off-pump group and in 14 patients (23%) in the on-pump group (p = 0.23), no patients underwent redo coronary artery bypass grafting. Off-pump coronary artery bypass grafting provides comparable 15-year outcomes to on-pump coronary artery bypass grafting.

Identifiants

pubmed: 35953640
doi: 10.1007/s11748-022-01854-y
pii: 10.1007/s11748-022-01854-y
doi:

Types de publication

Journal Article Randomized Controlled Trial

Langues

eng

Sous-ensembles de citation

IM

Pagination

151-157

Informations de copyright

© 2022. The Author(s), under exclusive licence to The Japanese Association for Thoracic Surgery.

Références

Lamy A, Devereaux PJ, Prabhakaran D, Taggart DP, Hu S, Paolasso E, et al. Effects of off-pump and on-pump coronary-artery bypass grafting at 1 year. N Engl J Med. 2013;368:1179–88.
doi: 10.1056/NEJMoa1301228 pubmed: 23477676
Lamy A, Devereaux PJ, Prabhakaran D, Taggart DP, Hu S, Straka Z, et al. Five-year outcomes after off-pump or on-pump coronary-artery bypass grafting. N Engl J Med. 2016;375:2359–68.
doi: 10.1056/NEJMoa1601564 pubmed: 27771985
Shroyer AL, Hattler B, Wagner TH, Collins JF, Baltz JH, Quin JA, et al. Five-year outcomes after on-pump and off-pump coronary-artery bypass. N Engl J Med. 2017;377:623–32.
doi: 10.1056/NEJMoa1614341 pubmed: 28813218
Kobayashi J, Tashiro T, Ochi M, Yaku H, Watanabe G, Satoh T, et al. Early outcome of a randomized comparison of off-pump and on-pump multiple arterial coronary revascularization. Circulation. 2005;112:I338–43.
doi: 10.1161/CIRCULATIONAHA.104.524504 pubmed: 16159843
Takagi H, Umemoto T. Worse long-term survival after off-pump than on-pump coronary artery bypass grafting. J Thorac Cardiovasc Surg. 2014;148:1820–9.
doi: 10.1016/j.jtcvs.2014.05.034 pubmed: 24946969
Chikwe J, Lee T, Itagaki S, Adams DH, Egorova NN. Long-term outcomes after off-pump versus on-pump coronary artery bypass grafting by experienced surgeons. J Am Coll Cardiol. 2018;72:1478–86.
doi: 10.1016/j.jacc.2018.07.029 pubmed: 30236310
Benedetto U, Caputo M, Patel NN, Fiorentino F, Bryan A, Angelini GD. Long-term survival after off-pump versus on-pump coronary artery bypass graft surgery. Does completeness of revascularization play a role? Int J Cardiol. 2017;246:32–6.
doi: 10.1016/j.ijcard.2017.04.087 pubmed: 28499666
Benedetto U, Lau C, Caputo M, Kim L, Feldman DN, Ohmes LB, et al. Comparison of outcomes for off-pump versus on-pump coronary artery bypass grafting in low-volume and high-volume centers and by low-volume and high-volume surgeons. Am J Cardiol. 2018;121:552–7.
doi: 10.1016/j.amjcard.2017.11.035 pubmed: 29291888
Benedetto U, Caputo M, Mariscalco G, Gaudino M, Chivasso P, Bryan A, et al. Impact of multiple arterial grafts in off-pump and on-pump coronary artery bypass surgery. J Thorac Cardiovasc Surg. 2017;153:300-9.e306.
doi: 10.1016/j.jtcvs.2016.10.084 pubmed: 27955911
Kirmani BH, Guo H, Ahmadyur O, Bittar MN. Long-term survival following on-pump and off-pump coronary artery bypass graft surgery: a propensity score-matched analysis. Eur J Cardiothorac Surg. 2019;56:1147–53.
doi: 10.1093/ejcts/ezz250 pubmed: 31740974
Gaudino M, Benedetto U, Fremes S, Biondi-Zoccai G, Sedrakyan A, Puskas JD, et al. Radial-artery or saphenous-vein grafts in coronary-artery bypass surgery. N Engl J Med. 2018;378:2069–77.
doi: 10.1056/NEJMoa1716026 pubmed: 29708851
Ruttmann E, Dietl M, Feuchtner GM, Metzler B, Bonaros N, Taggart DP, et al. Long-term clinical outcome and graft patency of radial artery and saphenous vein grafts in multiple arterial revascularization. J Thorac Cardiovasc Surg. 2019;158:442–50.
doi: 10.1016/j.jtcvs.2018.10.135 pubmed: 30551960
Kowalewski M, Pawliszak W, Malvindi PG, Bokszanski MP, Perlinski D, Raffa GM, et al. Off-pump coronary artery bypass grafting improves short-term outcomes in high-risk patients compared with on-pump coronary artery bypass grafting: meta-analysis. J Thorac Cardiovasc Surg. 2016;151:60-77 e61-58.
doi: 10.1016/j.jtcvs.2015.08.042 pubmed: 26433633
Zhao DF, Edelman JJ, Seco M, Bannon PG, Wilson MK, Byrom MJ, et al. Coronary artery bypass grafting with and without manipulation of the ascending aorta: a network meta-analysis. J Am Coll Cardiol. 2017;69:924–36.
doi: 10.1016/j.jacc.2016.11.071 pubmed: 28231944

Auteurs

Naoki Tadokoro (N)

Department of Cardiovascular Surgery, National Cerebral and Cardiovascular Center, 6-1 Kishibeshimmachi, Suita, Osaka, Japan.
Department of Cardiovascular Surgery, Keio University School of Medicine, Shinjuku-ku, Tokyo, Japan.

Satsuki Fukushima (S)

Department of Cardiovascular Surgery, National Cerebral and Cardiovascular Center, 6-1 Kishibeshimmachi, Suita, Osaka, Japan. s.fukushima@ncvc.go.jp.

Kimito Minami (K)

Department of Surgical Intensive Care, National Cerebral and Cardiovascular Center, Suita, Osaka, Japan.

Yusuke Shimahara (Y)

Department of Cardiovascular Surgery, National Cerebral and Cardiovascular Center, 6-1 Kishibeshimmachi, Suita, Osaka, Japan.

Naonori Kawamoto (N)

Department of Cardiovascular Surgery, National Cerebral and Cardiovascular Center, 6-1 Kishibeshimmachi, Suita, Osaka, Japan.

Takashi Kakuta (T)

Department of Cardiovascular Surgery, National Cerebral and Cardiovascular Center, 6-1 Kishibeshimmachi, Suita, Osaka, Japan.

Satoshi Numata (S)

Division of Cardiovascular Surgery, Kyoto Prefectural University of Medicine, Kyoto, Kyoto, Japan.

Hitoshi Yaku (H)

Division of Cardiovascular Surgery, Kyoto Prefectural University of Medicine, Kyoto, Kyoto, Japan.

Hirofumi Takemura (H)

Department of Thoracic, Cardiovascular and General Surgery, Kanazawa University, Takara-machi, Kanazawa, Japan.

Kenji Iino (K)

Department of Thoracic, Cardiovascular and General Surgery, Kanazawa University, Takara-machi, Kanazawa, Japan.

Masami Ochi (M)

Department of Cardiovascular Surgery, Nippon Medical School, Bunkyo-Ku, Tokyo, Japan.

Yosuke Ishii (Y)

Department of Cardiovascular Surgery, Nippon Medical School, Bunkyo-Ku, Tokyo, Japan.

Hideichi Wada (H)

Department of Cardiovascular Surgery, Fukuoka University, Fukuoka, Japan.

Noritoshi Minematsu (N)

Department of Cardiovascular Surgery, Fukuoka University, Fukuoka, Japan.

Hideyuki Shimizu (H)

Department of Cardiovascular Surgery, Keio University School of Medicine, Shinjuku-ku, Tokyo, Japan.

Junjiro Kobayashi (J)

Department of Cardiovascular Surgery, National Cerebral and Cardiovascular Center, 6-1 Kishibeshimmachi, Suita, Osaka, Japan.

Tomoyuki Fujita (T)

Department of Cardiovascular Surgery, National Cerebral and Cardiovascular Center, 6-1 Kishibeshimmachi, Suita, Osaka, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH